1. Potent and selective inhibition of CDK7 by novel covalent inhibitors. (December 2016) Authors: Satyam, L.; Poddutoori, R.; Mukherjee, S.; Marappan, S.; Gopinath, S.; Pothuganti, M.; Nayak, S.; Kaza, L.; Nandish, C.; Amith, A.; Ravindra, M.; Nagaraju, A.; Antony, T.; Pandit, C.; Chelur, S.; Daginakatte, G.; Samajdar, S.; Ramachandra, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7. (October 2020) Authors: Satyam, L.K.; Poddutoori, R.; Thiyagarajan, S.; Mukherjee, S.; Kaza, L.N.; Charamanna, K.; Marappan, S.; Samiulla, D.; Tiwari, N.K.; Devaraja, T.; Aravind, A.; Dhudashiya, A.A.; Booher, R.; Daginakatte, G.; Antony, T.; Chelur, S.; Nellore, K.; Giri, S.; Ramachandra, M.; Samajdar, S. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗